Dr. Muir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467Fax+1 919-684-8264
Summary
- Dr. Andrew Muir is a gastroenterologist in Durham, NC and is affiliated with multiple hospitals in the area, including Duke University Hospital and Duke Regional Hospital. He received his medical degree from Duke University School of Medicine and has been in practice 20 years. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology.
Education & Training
- Duke University HospitalFellowship, Gastroenterology, 1998 - 2000
- Duke University HospitalFellowship, Gastroenterology, 1996 - 1997
- Duke University HospitalResidency, Internal Medicine, 1993 - 1996
- Duke University School of MedicineClass of 1993
Certifications & Licensure
- CA State Medical License 2000 - Present
- NC State Medical License 1995 - 2025
- WV State Medical License 2013 - 2017
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Fellow American Gastroenterological Association, 2013
- Fellow American College of Physicians, 2007
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Hepatitis C Alcohol Reduction Treatment Start of enrollment: 2014 Oct 01
- Quality of Life in Patients With Primary Sclerosing Cholangitis Start of enrollment: 2016 Jul 01
- Hepatitis C Virus(HCV) Heart and Lung Study Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 48 citationsThe conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair M. Younossi, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu
Journal of Hepatology. 2018-12-01 - 235 citationsSimtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic SteatohepatitisStephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell, Mitchell L. Shiffman, Anna Mae Diehl
Gastroenterology. 2018-10-01 - 116 citationsSimtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the DiseaseAndrew J. Muir, Cynthia Levy, Harry L.A. Janssen, Aldo J. Montano-Loza, Mitchell L. Shiffman
Hepatology. 2019-02-01
Authored Content
- Rising Rates of Hepatitis C in Pregnancies in the United StatesMay 2022
Press Mentions
- Surge in Alcohol-Related Disease During Pandemic Reveals Unmet Need for TreatmentMay 31st, 2022
- What to Know if You Need a Liver Transplant for Hepatitis CAugust 27th, 2020
- Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C TreatmentApril 29th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: